Anti-PPARA antibody
Specifications
| Product type: | Primary antibody |
| Antigen: | PPARA |
| Immunogen: | Recombinant protein |
| Species immunized: | Mouse |
| Isotype: | IgG1 |
| Applications: | Western Blot (1:600-1:2000); Flow Cytometry (1:80-1:200) |
| Reactivity: | Human, Monkey |
| Clonality (clone number): | Monoclonal |
| Form: | Liquid |
| Buffer: | Tris-HCl buffer (pH7.4),1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide. |
| Concentration: | 1mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | hPPAR antibody |
| MGC2237 antibody | |
| MGC2452 antibody | |
| NR1C1 antibody | |
| Nuclear receptor subfamily 1 group C member 1 antibody | |
| OTTHUMP00000197740 antibody | |
| OTTHUMP00000197741 antibody | |
| Peroxisome proliferative activated receptor alpha antibody | |
| Peroxisome proliferator activated receptor alpha antibody | |
| Peroxisome proliferator-activated receptor alpha antibody | |
| PPAR antibody | |
| PPAR-alpha antibody | |
| ppara antibody | |
| PPARA_HUMAN antibody | |
| PPARalpha antibody |
Show More
Target information
Ligand-activated transcription factor. Key regulator of lipid metabolism. Activated by the endogenous ligand 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine (16:0/18:1-GPC). Activated by oleylethanolamide, a naturally occurring lipid that regulates satiety. Receptor for peroxisome proliferators such as hypolipidemic drugs and fatty acids. Regulates the peroxisomal beta-oxidation pathway of fatty acids. Functions as transcription activator for the ACOX1 and P450 genes. Transactivation activity requires heterodimerization with RXRA and is antagonized by NR2C2. May be required for the propagation of clock information to metabolic pathways regulated by PER2.
Provider
Erpantech Laboratory